Intellectual Property India Publishes Patent Application for 'Fused Tricyclic Parp1 Inhibitor, Preparation Method Therefor, And Use Thereof' Filed by Haihe Biopharma Co. Ltd.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517054883 A) filed by Haihe Biopharma Co. Ltd., Shanghai, on June 6, for 'fused tricyclic parp1 inhibitor, preparation method therefor, and use thereof.'

Inventor(s) include Gao, Shanyun; Hou, Yingjie; Li, Jingjing; Zhang, Chaobo; Xu, Yanxiao; Tu, Wangyang; Yu, Bing; Zhang, Yixiang; and Li, Leping.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a fused tricyclic PARP1 inhibitor, a preparation method therefor, and a use thereof. In particular, the present invention relates to a compound capable of inhibiting p...